Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-29

Clinical Trial Update: Hemostatic Effect of Intrauterine Instillation Of Tranexamic Acid In Hysteroscopic Myomectomy [Phase 3]

View source ↗

Summary

A Phase 3 study is investigating intrauterine tranexamic acid to reduce blood loss during hysteroscopic myomectomy. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Ain Shams University | Conditions: Surgical Blood Loss, Fibroid | Phase 3 | Status: UNKNOWN